Bank Of America Corp Acurx Pharmaceuticals, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 117 shares of ACXP stock, worth $49. This represents 0.0% of its overall portfolio holdings.
Number of Shares
117
Previous 113
3.54%
Holding current value
$49
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ACXP
# of Institutions
31Shares Held
1.42MCall Options Held
13.6KPut Options Held
4K-
Vanguard Group Inc Valley Forge, PA529KShares$222,3260.0% of portfolio
-
Prospect Financial Services LLC Melville, NY329KShares$138,2110.15% of portfolio
-
Geode Capital Management, LLC Boston, MA147KShares$61,5300.0% of portfolio
-
Morgan Stanley New York, NY106KShares$44,6040.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA48.4KShares$20,3170.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $4.85M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...